Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 4 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 962.87 | 1445 / 1445 | 100% | 9.93 | 183 / 183 |
| ovary | 100% | 638.83 | 180 / 180 | 100% | 17.44 | 430 / 430 |
| thymus | 100% | 1353.44 | 653 / 653 | 100% | 18.93 | 604 / 605 |
| intestine | 100% | 1219.16 | 966 / 966 | 100% | 18.76 | 525 / 527 |
| uterus | 100% | 713.96 | 170 / 170 | 100% | 15.90 | 457 / 459 |
| pancreas | 100% | 941.34 | 328 / 328 | 99% | 17.02 | 177 / 178 |
| prostate | 100% | 1056.27 | 245 / 245 | 99% | 21.06 | 499 / 502 |
| brain | 99% | 624.87 | 2626 / 2642 | 100% | 13.16 | 705 / 705 |
| kidney | 100% | 1371.42 | 89 / 89 | 99% | 16.94 | 894 / 901 |
| stomach | 100% | 1084.10 | 359 / 359 | 99% | 15.27 | 283 / 286 |
| lung | 100% | 931.85 | 577 / 578 | 99% | 16.10 | 1144 / 1155 |
| bladder | 100% | 960.76 | 21 / 21 | 99% | 19.58 | 497 / 504 |
| skin | 100% | 955.82 | 1809 / 1809 | 99% | 16.97 | 465 / 472 |
| breast | 100% | 888.22 | 459 / 459 | 98% | 13.53 | 1099 / 1118 |
| adrenal gland | 100% | 1251.49 | 258 / 258 | 97% | 11.04 | 224 / 230 |
| liver | 100% | 901.79 | 226 / 226 | 96% | 12.11 | 391 / 406 |
| adipose | 100% | 821.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 17.08 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 25.96 | 29 / 29 |
| spleen | 100% | 1608.18 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 17.37 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 24.90 | 1 / 1 |
| muscle | 100% | 919.41 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 820.81 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 1163.02 | 916 / 929 | 0% | 0 | 0 / 0 |
| heart | 98% | 1093.03 | 845 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0052751 | Molecular function | GDP-mannose hydrolase activity |
| GO_0008768 | Molecular function | UDP-sugar diphosphatase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | NUDT22 |
| Protein name | Nudix hydrolase 22 Nudix (Nucleoside diphosphate linked moiety X)-type motif 22, isoform CRA_d (Nudix hydrolase 22) Uridine diphosphate glucose pyrophosphatase NUDT22 (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 22) (Nudix motif 22) |
| Synonyms | hCG_2039175 PP11246 |
| Description | FUNCTION: Hydrolyzes UDP-glucose to glucose 1-phosphate and UMP and UDP-galactose to galactose 1-phosphate and UMP. Preferred substrate is UDP-glucose. . |
| Accessions | G3V1M6 ENST00000279206.8 [Q9BRQ3-1] ENST00000543358.5 ENST00000534929.1 ENST00000441250.6 [Q9BRQ3-3] ENST00000428347.2 H0YGG2 ENST00000539325.1 F5H1N0 J3KQJ3 Q9BRQ3 ENST00000535000.1 |